|
1）van Beusechem VW, Grill J, Mastenbroek DC, et al. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished. J Virol. 2002; 76: 2753-62
|
|
|
|
2）Tanaka T, Huang J, Hirai S, et al. Carcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors. Clin Cancer Res. 2006; 12: 3803-13
|
|
|
|
|
|
3）Volpers C, Thirion C, Biermann V, et al. Antibody-mediated targeting of an adenovirus vector modified to contain a synthetic immunoglobulin g-binding domain in the capsid. J Virol. 2003; 77: 2093-104
|
|
|
|
|
|
4）Suzuki K, Nakamura K, Kato K, et al. Exploration of target molecules for prostate cancer gene therapy. Prostate. 2007; 67: 1163-73
|
|
|
|
|
|
5）Kai M, Wada I, Imai S, et al. Cloning and characterization of two human isozymes of Mg2＋- independent phosphatidic acid phosphatase. J Biol Chem. 1997; 272: 24572-8
|
|
|
|
|
|
6）Bernard J, Treton D, Vermot-Desroches C, et al. Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13Ralpha2 as a decoy receptor for IL13. Lab Invest. 2001; 81: 1223-31
|
|
|
|
|
|
7）Kioi M, Husain SR, Croteau D, et al. IL-13PE Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy. Technol Cancer Res Treat. 2006; 5: 239-50
|
|
|
|
|
|
8）Feng N, Lugli SM, Schnyder B, et al. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2. Lab Invest. 1998; 78: 591-602
|
|
|
|
|